Murawaki Y - Search Results

1

Expression of oxidative stress-related molecules in circulating leukocytes and urine in patients with chronic viral hepatitis.

Saeki T, Ichiba M, Tanabe N, Ueki M, Okamoto K, Matsunaga Y, Hosho K, Kanbe T, Tsuchiya H, Kurimasa A, Yamada S, Hirooka Y, Hisatome I, Kishimoto Y, Suou T, Murawaki Y, Kawasaki H, Yodoi J, Shiota G. Saeki T, et al. Among authors: murawaki y. Liver Int. 2006 Mar;26(2):157-65. doi: 10.1111/j.1478-3231.2005.01213.x. Liver Int. 2006. PMID: 16448453

2

Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma.

Ichiba M, Maeta Y, Mukoyama T, Saeki T, Yasui S, Kanbe T, Okano J, Tanabe Y, Hirooka Y, Yamada S, Kurimasa A, Murawaki Y, Shiota G. Ichiba M, et al. Among authors: murawaki y. Liver Int. 2003 Oct;23(5):338-45. doi: 10.1034/j.1478-3231.2003.00868.x. Liver Int. 2003. PMID: 14708894

3

Retinoic acid receptor alpha dominant negative form causes steatohepatitis and liver tumors in transgenic mice.

Yanagitani A, Yamada S, Yasui S, Shimomura T, Murai R, Murawaki Y, Hashiguchi K, Kanbe T, Saeki T, Ichiba M, Tanabe Y, Yoshida Y, Morino S, Kurimasa A, Usuda N, Yamazaki H, Kunisada T, Ito H, Murawaki Y, Shiota G. Yanagitani A, et al. Among authors: murawaki y. Hepatology. 2004 Aug;40(2):366-75. doi: 10.1002/hep.20335. Hepatology. 2004. PMID: 15368441

4

Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.

Ueki M, Koda M, Yamamoto S, Matsunaga Y, Murawaki Y. Ueki M, et al. Among authors: murawaki y. J Gastroenterol. 2006 Oct;41(10):996-1004. doi: 10.1007/s00535-006-1891-1. Epub 2006 Nov 9. J Gastroenterol. 2006. PMID: 17096069

5

FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C.

Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. Koda M, et al. Among authors: murawaki y. Hepatology. 2007 Feb;45(2):297-306. doi: 10.1002/hep.21520. Hepatology. 2007. PMID: 17256741

6

Aberrant expression of selenoproteins in the progression of colorectal cancer.

Murawaki Y, Tsuchiya H, Kanbe T, Harada K, Yashima K, Nozaka K, Tanida O, Kohno M, Mukoyama T, Nishimuki E, Kojo H, Matsura T, Takahashi K, Osaki M, Ito H, Yodoi J, Murawaki Y, Shiota G. Murawaki Y, et al. Cancer Lett. 2008 Feb 8;259(2):218-30. doi: 10.1016/j.canlet.2007.10.019. Epub 2007 Dec 3. Cancer Lett. 2008. PMID: 18054426

7

The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat.

Matono T, Koda M, Tokunaga S, Sugihara T, Ueki M, Murawaki Y. Matono T, et al. Among authors: murawaki y. Int J Mol Med. 2010 Jun;25(6):875-82. doi: 10.3892/ijmm_00000417. Int J Mol Med. 2010. PMID: 20428791

8

Effects of Sho-Saiko-to on hepatocarcinogenesis and 8-hydroxy-2'-deoxyguanosine formation.

Shiota G, Maeta Y, Mukoyama T, Yanagidani A, Udagawa A, Oyama K, Yashima K, Kishimoto Y, Nakai Y, Miura T, Ito H, Murawaki Y, Kawasaki H. Shiota G, et al. Among authors: murawaki y. Hepatology. 2002 May;35(5):1125-33. doi: 10.1053/jhep.2002.33066. Hepatology. 2002. PMID: 11981762

9

Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats.

Oyama K, Shiota G, Ito H, Murawaki Y, Kawasaki H. Oyama K, et al. Among authors: murawaki y. Carcinogenesis. 2002 May;23(5):885-92. doi: 10.1093/carcin/23.5.885. Carcinogenesis. 2002. PMID: 12016164

10

The proMMP-2 activation rate in patients with chronic viral liver disease.

Murawaki Y, Ikuta Y, Koda M, Okamoto K, Mimura K. Murawaki Y, et al. Clin Chim Acta. 2002 Oct;324(1-2):99-103. doi: 10.1016/s0009-8981(02)00239-5. Clin Chim Acta. 2002. PMID: 12204430

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters